Friday, 23 Oct 2026
Empowering Chinese Pharma’s Global Expansion
Contact US
Home
About US
Policy Hub
Categories
Drug
Company
Deals
Policy / Regulatory
Medical Device
R&D
Legal / IP
Digital
Privacy Policy
Contact US
My News
Cancer
Clinical trial approval / initiation
Product approvals
Clinical trial results
Finance
ADC / XDC
Finanical Reports
Biotech
Market approval filings
PD-1/L1
Read History
Search
Pages
Home
Blog Index
POLICY HUB
Contact Us
Personalized
Read History
Categories
Company
Drug
Policy / Regulatory
Medical Device
R&D
Digital
Legal / IP
Deals
Have an existing account?
Sign In
Follow US
Company
Drug
Sanofi’s Qfitlia Approved by FDA for Hemophilia A and B Prophylaxis
March 31, 2025
Company
Drug
Brii Biosciences Presents Elebsiran Phase II Data at APASL 2025 Meeting
March 31, 2025
Company
Akeso Biopharma Reports 53% Revenue Decline in 2024 Despite Growth in Product Sales
March 31, 2025
Company
Drug
IASO Biotherapeutics’ Fucaso Approved in Macao for Relapsed Multiple Myeloma
March 31, 2025
Company
Drug
Eli Lilly Launches Kisunla in China for Early Alzheimer’s Treatment
March 31, 2025
Company
Drug
Laekna Submits Revised Protocol for LAE102 Obesity Trial with Eli Lilly
March 31, 2025
Company
Deals
Apollomics Partners with LaunXP for Vebreltinib in Asian NSCLC Treatment
April 15, 2025
Company
Deals
Bioray Biopharmaceutical Expands to Turkey with Three Key Drugs, Marking International Milestone
April 15, 2025
Company
EClinCloud Secures New Funding to Accelerate AI Innovation in Clinical Research
March 30, 2025
Medical Device
Policy / Regulatory
China Tightens Medical Device Quality Oversight: 2025 Inspection Plan Unveiled
March 29, 2025
Policy / Regulatory
Policy Analysis: Shanghai’s 2025 Pharmaceutical Procurement Regulation and Market Implications
March 29, 2025
Policy / Regulatory
Guangdong Accelerates Centralized Procurement for Apixaban and Key Therapeutics
March 29, 2025
1
2
…
205
206
207
208
209
…
289
290
Welcome to Fineline Cube!
Username or Email Address
Password
Remember me
Lost your password?
